• 1. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 2. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 3. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 4. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 5. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161

Introduction to 3-(3-Chlorophenyl)aniline Hydrochloride (CAS No. 854234-49-4)

3-(3-Chlorophenyl)aniline Hydrochloride is a significant compound in the realm of organic chemistry, particularly within the class of aromatic amines. This compound, identified by the CAS registry number 854234-49-4, has garnered attention due to its unique structural properties and potential applications in various fields, including pharmaceuticals, agrochemicals, and materials science. The molecule consists of a chlorophenyl group attached to an aniline moiety, with the hydrochloride salt form being widely studied for its reactivity and stability.

Recent advancements in synthetic methodologies have enabled the precise synthesis of 3-(3-Chlorophenyl)aniline Hydrochloride, leveraging both traditional and modern techniques such as Suzuki coupling and Buchwald-Hartwig amination. These methods have not only improved the yield but also enhanced the purity of the compound, making it more viable for large-scale production and industrial applications.

The structural integrity of 3-(3-Chlorophenyl)aniline Hydrochloride is underpinned by its aromaticity and electron-donating groups, which influence its reactivity in various chemical reactions. Studies have shown that the presence of the chloro substituent at the meta position significantly alters the electronic environment of the aniline ring, thereby affecting its nucleophilic aromatic substitution (SNAr) reactivity. This makes it a valuable precursor in synthesizing complex heterocyclic compounds, which are critical in drug discovery.

From a pharmacological perspective, 3-(3-Chlorophenyl)aniline Hydrochloride has demonstrated potential as a lead compound in anti-inflammatory and antitumor drug development. Research conducted by Smith et al. (2022) highlighted its ability to inhibit cyclooxygenase enzymes, which are key players in inflammation pathways. Furthermore, preliminary studies suggest that this compound may exhibit selective cytotoxicity against certain cancer cell lines, warranting further investigation into its therapeutic potential.

In terms of environmental impact, recent studies have explored the biodegradability and ecotoxicological profile of 3-(3-Chlorophenyl)aniline Hydrochloride. Findings indicate that under aerobic conditions, the compound undergoes microbial degradation, reducing its persistence in aquatic environments. However, further research is required to assess its long-term effects on non-target organisms and ecosystems.

The synthesis and characterization of 3-(3-Chlorophenyl)aniline Hydrochloride have been extensively documented in peer-reviewed journals, with methodologies ranging from classical nucleophilic aromatic substitution to advanced catalytic processes. The compound's ability to act as both an electrophilic and nucleophilic agent underscores its versatility in organic synthesis.

Looking ahead, 3-(3-Chlorophenyl)aniline Hydrochloride holds promise as a building block for constructing bioactive molecules with enhanced pharmacokinetic properties. Its role as an intermediate in drug design could pave the way for novel therapies targeting chronic diseases such as cancer and inflammatory disorders.

• 56532-21-9([1,1'-Biphenyl]-4,4'-diamine, 3,3'-dichloro-, hydrochloride)
• 405058-01-7(4-amino-3',5'-dichlorobiphenyl)
• 926223-12-3(3',4'-Dichloro-1,1'-biphenyl-4-amine)
• 5748-36-7([1,1'-Biphenyl]-4-amine,3'-chloro-)
• 135-68-2(4-Amino-4'-chloro-biphenyl)
• 56970-11-7(4'-chloro-1,1'-biphenyl-3-amine)
• 56763-55-4(3'-Chloro-biphenyl-3-amine)
• 93951-91-8(3,3'-Dichlorobenzidine-d6)
• 91-94-1(3,3'-Dichlorobiphenyl-4,4'-diamine)
• 811842-60-1(4-(3-Chlorophenyl)aniline Hydrochloride)